Candesartan cilexetil in cardiovascular disease.

about

Targeting angiotensin II type I receptors to reduce the risk of stroke in patients with hypertension.Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.

P2860

Q36425956-99C62C7D-2127-4A29-B9B6-12C42EA63AA6 Q54681966-A360FD00-30E5-4DE9-9F51-9574BE384D8E

P2860

Candesartan cilexetil in cardiovascular disease.

Item

http://www.wikidata.org/entity/Q35925682

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Candesartan cilexetil in cardiovascular disease.

@ast

Candesartan cilexetil in cardiovascular disease.

@en

type

Item

label

Candesartan cilexetil in cardiovascular disease.

@ast

Candesartan cilexetil in cardiovascular disease.

@en

prefLabel

Candesartan cilexetil in cardiovascular disease.

@ast

Candesartan cilexetil in cardiovascular disease.

@en

P1476

Candesartan cilexetil in cardiovascular disease

@en

P2093

Amy Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data.

Angiotensin II type 1 receptor blockers.

Prognostic implications of left ventricular hypertrophy.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Clinical pharmacology of antihypertensive drugs.

Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension.

Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators.

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

P304

829-835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2.6.829

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vasilios Papademetriou

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15500428

http://www.w3.org/2001/XMLSchema#string

Candesartan cilexetil in cardiovascular disease.

about

P2860

P2860

Candesartan cilexetil in cardiovascular disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698